Most people assume any small device that amplifies sound and sits in your ear is basically a hearing aid. That assumption is wrong, and it’s an expensive one to get wrong in either direction — either overpaying for medical-grade technology you don’t need, or underbuying a device that can’t actually address your hearing loss.
Cost Comparison: PSAPs vs. Hearing Aids
| Category | Personal Sound Amplifiers (PSAPs) | Hearing Aids (OTC + Prescription) |
|---|---|---|
| Price range | $20–$300 | $200–$7,000 |
| FDA regulation | None — general consumer electronics | Yes — medical device category |
| Designed for | Normal hearing, situational amplification | Diagnosed hearing loss |
| Frequency-specific programming | No, or very limited | Yes, calibrated to audiogram |
| Output safety limits | Not regulated | FDA-mandated limits to prevent further damage |
| Legal marketing claims | Cannot claim to treat hearing loss | Can be marketed and sold specifically for hearing loss |
The Legal Line That Separates Them
This distinction isn’t just marketing language — it’s federal regulation. The FDA classifies true hearing aids (both prescription and the OTC category created by the 2022 rule) as medical devices, subject to safety, output, and labeling requirements. PSAPs are explicitly marketed and regulated as consumer electronics for people with normal hearing who want situational amplification — hunters listening for distant game, birdwatchers, or people wanting to eavesdrop on a quiet conversation across a room. By law, PSAP manufacturers cannot claim their products treat hearing loss, precisely because the products aren’t designed, tested, or regulated for that purpose.
Why the Confusion Happens (And Who Benefits From It)
Some PSAP manufacturers use language that skirts close to hearing aid marketing without technically crossing the legal line — phrases like “hearing amplifier for seniors” or “hear every whisper” that imply medical benefit without explicitly claiming to treat hearing loss. The Hearing Loss Association of America (HLAA) has flagged this pattern as one of the most persistent sources of consumer confusion in the hearing device market, particularly affecting older adults searching online for affordable hearing help who land on a $40 PSAP believing it’s equivalent to a real hearing aid.
- Check for “FDA-registered” or “FDA OTC hearing aid” language explicitly — PSAPs cannot legally use this exact phrasing
- Look for frequency-specific programming or a self-fitting app — genuine hearing aids include this; most PSAPs offer only basic overall volume control
- Search the product name in the FDA’s device database at accessdata.fda.gov — registered hearing aids will appear; PSAPs will not
Why This Matters Beyond Just Wasting Money
Using a PSAP to compensate for actual, diagnosed hearing loss isn’t just an ineffective purchase — it can be counterproductive. PSAPs lack the frequency-specific amplification that addresses your particular hearing loss pattern, and without output safety limits, some can actually deliver amplification levels that risk further hearing damage with prolonged use, particularly for anyone with existing hearing loss who needs precisely calibrated amplification rather than generic volume boosting.
When a PSAP Is Genuinely the Right Tool
PSAPs aren’t inherently bad products — they’re simply built for a different purpose. Legitimate, useful cases include:
- Hunters and birdwatchers wanting to detect distant sounds with normal hearing
- Situational eavesdropping-type use — following a lecture from the back of a large room, for instance
- Temporary use in a specific low-noise environment without a diagnosed hearing condition
If you have any suspected hearing loss at all, the right next step is a hearing test — not a PSAP purchase — to determine whether an OTC or prescription hearing aid is actually needed.
The Cost Argument for Skipping PSAPs Entirely
Given that legitimate FDA-registered OTC hearing aids now start around $200–$300/pair — not dramatically more than many PSAPs — the cost savings of choosing a PSAP over a real OTC hearing aid is often smaller than people assume, while the functional gap (frequency-specific programming, safety limits, self-fitting apps validated in clinical studies) is significant. For anyone with actual hearing loss, that narrow price gap makes the OTC hearing aid the clearly better value.
Never substitute a PSAP for a hearing test if you suspect hearing loss. A PSAP cannot diagnose your hearing loss pattern, cannot be safely calibrated to your specific needs, and using one instead of seeking proper evaluation can delay the treatment of an underlying condition — including, in rare cases, medically treatable causes of hearing changes that a PSAP would never reveal.
If you’re shopping online and a listing’s price and vague language feel too good to be true for a hearing loss solution, check the FDA database before buying — it takes two minutes and prevents a genuinely common, costly mistake.
Frequently Asked Questions
Personal sound amplification products (PSAPs) are consumer electronics intended for people with normal hearing who want to amplify sound in specific situations (like birdwatching), while hearing aids — both OTC and prescription — are FDA-regulated medical devices specifically designed and tested to treat diagnosed hearing loss.
It's not recommended. PSAPs are not FDA-regulated for treating hearing loss, lack the frequency-specific programming and safety output limits that hearing aids require, and using one to compensate for actual hearing loss can result in inadequate or even unsafe amplification levels.
PSAPs skip the FDA regulatory requirements, clinical testing, and frequency-specific programming capability that hearing aids must include, resulting in simpler, less expensive electronics — but also a product not designed or validated to safely treat actual hearing loss.